Table 2.
PLT (×109/L) | Cases/Controls | Unadjusted | Adjusted | ||
---|---|---|---|---|---|
P value | OR (95% CI) | P value | OR (95% CI) | ||
Per SD | 0.015 | 1.23 (1.04-1.46) | 0.018 | 1.29 (1.05-1.60) | |
By cutoff | |||||
D1 (< 296) | 167/200 | ref. | ref. | ||
D2 (≥ 296) | 85/52 | 0.001 | 2.01 (1.34-3.02) | 0.001 | 2.18 (1.38-3.47) |
Interquartile | |||||
Q1~Q3 (< 305) | 175/203 | ref. | ref. | ||
Q4 (≥ 305) | 77/49 | 0.006 | 1.79 (1.19-2.71) | 0.013 | 1.82 (1.14-2.94) |
Notes: The 1-year survival ORs of cancer cachexia patients were estimated by modeling PLT as a continuous variable and using conditional logistic regression as the dichotomy and quartile. The analyses were adjusted for BMI, HGS, MAC, albumin, TBIL, WBC, RBC, TSF, chemotherapy, radiotherapy, surgery. PLT: platelet count; CI: confidence interval; OR: odds ratio; P: probability; D: dichotomy; Q: quarter; BMI: body mass index; HGS: hand grip strength; MAC: mid-upper arm circumference; TBIL: total bilirubin; WBC: white blood cell; RBC: red blood cell; TSF: triceps skin fold.